Viatris Archives - Express Pharma

Gilead Sciences signs licencing agreements with six companies to manufacture, commercialise Lenacapavir

Kotak Alt acquires API business of Matrix Pharma

Viatris gets global Minimised Risk of AMR Certification

Biocon Biologics completes integration of Viatris Biosimilars’ Business in North America

Viatris gets tentative nod from US FDA for Abacavir/Dolutegravir/Lamivudine to treat paediatric HIV patients

New report sets out clear steps pharma cos to curb AMR risk in antibiotic production

Biocon Biologics launches Hulio biosimilar in US

Biocon Biologics completely acquires Viatris’s global biosimilars business

Europe’s generic drug makers say they may cut output due to energy bills

Balancing profitability with sustainability